Wordt geladen...

Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials

Advances in the understanding of cancer immunotherapy and the development of multiple checkpoint inhibitors have dramatically changed the current landscape of cancer treatment. Recent large-scale phase III trials (e.g. PHOCUS, OPTiM) are establishing use of oncolytic viruses as another tool in the c...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Transl Med
Hoofdauteurs: LaRocca, Christopher J., Warner, Susanne G.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Berlin Heidelberg 2018
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6234197/
https://ncbi.nlm.nih.gov/pubmed/30426287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0214-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!